Sign in
Not yet recruitingNo phase

Studying wound fluid and biofilm from adults with long-lasting wounds that do not heal

Uses leftover wound material from 72 adults to study healing treatments and biomarkers.

Key facts

Who runs it
Barbara Wolff-Winiski
Where
Germany1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
INJECTHEAL - Investigation of Chronic Wound Exudate and Biofilm
Status
Not yet recruiting
People taking part
72 people, planned
Started
1 Aug 2026
Expected to end
10 Apr 2028
Type of study
Observational
Treatments tested
  • standard of care
Record updated
4 August 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with chronic, non-healing deep wounds. Fluid and tissue removed from the wound during routine care will be collected and studied.

Age
18 years and older
Sex
All sexes
Disease stage
Deep cavity wounds that are not healing or heal slowly. These include leg or foot ulcers from type I or type II diabetes, arterial leg ulcers, and wounds after surgery.
Earlier treatment
People must be getting routine negative pressure wound therapy (a suction treatment for wounds). They must also have routine removal of dead tissue with a blade or surgery.

Main reasons for not taking part

  • Not enough wound fluid (at least 2 ml per visit is needed)
  • Abuse of several substances
  • Proven active infection with HIV, hepatitis C or HPV
  • Being pregnant
  • Not able to give or not giving written consent

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • Age ≥ 18 years
  • Type I or type II diabetes with lower extremity deep cavity ulcers
  • Arterial leg ulcers with lower extremity deep cavity ulcers
  • Surgical deep cavity non-healing wounds
  • Wounds with delayed healing
  • Routine treatment with negative pressure wound therapy
  • Routine sharp or surgical debridement
  • Sufficient wound exudate available (min. of 2 ml per visit)
  • Patient is informed about the study and has given informed consent

Who cannot take part

  • Proven active infections with HIV, hepatitis C or HPV
  • Age ≤ 18 years
  • Multiple substance abuse (poly-toxicomania)
  • No signed declaration of consent or incapable of giving an informed written consent
  • Active pregnancy

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This prospective observational study will collect routine clinical waste material from 72 adults with chronic, non-healing wounds, including wound exudate from negative pressure therapy containers or sponges and wound biofilm/debridement material. Samples and routine clinical wound data will be used to test INJECTHEAL hydrogel components and other wound healing therapeutics, and identify molecular, biochemical, and microbiological biomarkers linked to wound healing.

The group in the trial

  • Patients with chronic wounds

    Treatment: standard of care

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
INJECTHEAL- Profiling of Potential Wound Healing Therapeutics in Cellular Assays in the Presence of Wound Exudates
Plain-language title
Studying wound fluid and biofilm from adults with long-lasting wounds that do not healGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Record updated
4 August 2026